Congestive Nephropathy

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Mar 10

PMID 35270191

Authors

Luis D Marco

Affiliations

Soon will be listed here.

Abstract

The complex interaction between cardiac and renal functions is known. However, when these functions are disrupted, many intricate and sensitive interactions between these organs are failed by several pathophysiological ways. As a result, this malfunction is clinically evident by sign and symptoms associated to intravascular and interstitial congestion. In this sense, the adverse impact of venous congestion on renal function has long been recognized. Currently, the presence of a specific subtype of nephropathy associated to congestion has been suggested. Even though no diagnosis criteria has been clearly stablished, and no renal specific histological pattern were reported; studies regarding this issue may help to improve the handling and therapeutic principles in affected patients.

Citing Articles

Mitral Valve Transcatheter Edge-to-Edge Repair (MV-TEER) in Patients with Secondary Mitral Regurgitation Improves Hemodynamics, Enhances Renal Function, and Optimizes Quality of Life in Patients with Advanced Renal Insufficiency.

Markus B, Kreutz J, Chatzis G, Syntila S, Kuchenbuch J, Mueller C Biomedicines. 2024; 12(11).

PMID: 39595212 PMC: 11591953. DOI: 10.3390/biomedicines12112648.

Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography.

Wallbach M, Ajrab J, Bayram B, Pieper D, Schafer A, Luders S Clin Kidney J. 2024; 17(9):sfae234.

PMID: 39258260 PMC: 11384228. DOI: 10.1093/ckj/sfae234.

Early risk predictors of acute kidney injury and short-term survival during Impella support in cardiogenic shock.

Patsalis N, Kreutz J, Chatzis G, Syntila S, Choukeir M, Schieffer B Sci Rep. 2024; 14(1):17484.

PMID: 39080441 PMC: 11289486. DOI: 10.1038/s41598-024-68376-w.

Point-of-care ultrasonography spotlight: Could venous excess ultrasound serve as a shared language for internists and intensivists?.

Khan A, Saeed H, Haque I, Iqbal A, Du D, Koratala A World J Crit Care Med. 2024; 13(2):93206.

PMID: 38855280 PMC: 11155496. DOI: 10.5492/wjccm.v13.i2.93206.

Point-of-care ultrasound in diagnosis and management of congestive nephropathy.

Turk M, Robertson T, Koratala A World J Crit Care Med. 2023; 12(2):53-62.

PMID: 37034023 PMC: 10075049. DOI: 10.5492/wjccm.v12.i2.53.

References

Rossignol P, Hernandez A, Solomon S, Zannad F . Heart failure drug treatment. Lancet. 2019; 393(10175):1034-1044. DOI: 10.1016/S0140-6736(18)31808-7. View

Ronco C, Haapio M, House A, Anavekar N, Bellomo R . Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52(19):1527-39. DOI: 10.1016/j.jacc.2008.07.051. View

Galindo P, Gasca C, Argaiz E, Koratala A . Point of care venous Doppler ultrasound: Exploring the missing piece of bedside hemodynamic assessment. World J Crit Care Med. 2021; 10(6):310-322. PMC: 8613717. DOI: 10.5492/wjccm.v10.i6.310. View

Petrie M, Verma S, Docherty K, Inzucchi S, Anand I, Belohlavek J . Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes. JAMA. 2020; 323(14):1353-1368. PMC: 7157181. DOI: 10.1001/jama.2020.1906. View

Blair J, Pang P, Schrier R, Metra M, Traver B, Cook T . Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011; 32(20):2563-72. DOI: 10.1093/eurheartj/ehr238. View

de la Espriella R, Santas E, Zegri Reiriz I, Gorriz J, Marcos M, Nunez J . Quantification and Treatment of Congestion in Heart Failure: A Clinical and Pathophysiological Overview. Nefrologia (Engl Ed). 2021; . DOI: 10.1016/j.nefro.2021.04.006. View

Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V . Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2011; 5(1):54-62. DOI: 10.1161/CIRCHEARTFAILURE.111.963413. View

Dhaun N, Bellamy C, Cattran D, Kluth D . Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014; 85(5):1039-48. DOI: 10.1038/ki.2013.512. View

Lam C, Chandramouli C, Ahooja V, Verma S . SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects. J Am Heart Assoc. 2019; 8(20):e013389. PMC: 6818035. DOI: 10.1161/JAHA.119.013389. View

10.

Mullens W, Abrahams Z, Francis G, Sokos G, Taylor D, Starling R . Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009; 53(7):589-596. PMC: 2856960. DOI: 10.1016/j.jacc.2008.05.068. View

11.

Fudim M, Hernandez A, Felker G . Role of Volume Redistribution in the Congestion of Heart Failure. J Am Heart Assoc. 2017; 6(8). PMC: 5586477. DOI: 10.1161/JAHA.117.006817. View

12.

Boudoulas K, Boudoulas H . Cardiorenal interrelationship. Cardiology. 2011; 120(3):135-8. DOI: 10.1159/000334407. View

13.

Braam B, Cupples W, Joles J, Gaillard C . Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev. 2011; 17(2):161-75. DOI: 10.1007/s10741-011-9246-2. View

14.

Bhardwaj V, Vikneswaran G, Rola P, Raju S, Bhat R, Jayakumar A . Combination of Inferior Vena Cava Diameter, Hepatic Venous Flow, and Portal Vein Pulsatility Index: Venous Excess Ultrasound Score (VEXUS Score) in Predicting Acute Kidney Injury in Patients with Cardiorenal Syndrome: A Prospective Cohort Study. Indian J Crit Care Med. 2020; 24(9):783-789. PMC: 7584837. DOI: 10.5005/jp-journals-10071-23570. View

15.

Verbrugge F, Guazzi M, Testani J, Borlaug B . Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney. Circulation. 2020; 142(10):998-1012. PMC: 7482031. DOI: 10.1161/CIRCULATIONAHA.119.045409. View

16.

Santas E, Palau P, Bayes-Ge A, Nunez J . The emerging role of carbohydrate antigen 125 in heart failure. Biomark Med. 2020; 14(4):249-252. DOI: 10.2217/bmm-2019-0470. View

17.

de la Espriella R, Bayes-Genis A, Llacer P, Palau P, Minana G, Santas E . Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure. Eur J Intern Med. 2021; 95:67-73. DOI: 10.1016/j.ejim.2021.08.024. View

18.

de la Espriella R, Bayes-Genis A, Morillas H, Bravo R, Vidal V, Nunez E . Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes. ESC Heart Fail. 2020; 7(6):3792-3800. PMC: 7754982. DOI: 10.1002/ehf2.12965. View

19.

McMurray J, Solomon S, Inzucchi S, Kober L, Kosiborod M, Martinez F . Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019; 381(21):1995-2008. DOI: 10.1056/NEJMoa1911303. View

20.

Nunez J, de la Espriella R, Minana G, Santas E, Llacer P, Nunez E . Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review. Eur J Heart Fail. 2021; 23(9):1445-1457. DOI: 10.1002/ejhf.2295. View